EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia

Xiaoyan He, Wanting Huang, Xiong Wan, Xiaoya Li, Qiuhong Chang, Ling Ding iD

Journal of International Medical Research · 2023-03 · 51 (3)

DOI: 10.1177/03000605231162434 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of International Medical Research, online erschienen am 26.03.2023. Verfasst von Xiaoyan He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Chongqing University Jiangjin Hospital, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China. Hauptthemen laut MEDLINE: Cefoperazone, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beta-lactam antibiotics commonly cause immune thrombocytopenia. Cross-reactivity in patients with drug-induced immune thrombocytopenia has rarely been reported. In this study, we describe the case of a 79-year-old man who developed thrombocytopenia after receiving piperacillin–tazobactam for an acute exacerbation of chronic obstructive pulmonary disease, and he was successfully treated with meropenem and cefotiam. However, thrombocytopenia recurred after cefoperazone–sulbactam administration. This indicated that cross-reactivity of platelet-specific antibodies occurred between piperacillin–tazobactam and cefoperazone–sulbactam. However, the responsible drug structures remain unknown, requiring further investigation. Likewise, chemical structure similarities among beta-lactam antibiotics must be examined to determine the risk of immune thrombocytopenia in the clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefoperazonePurpura, Thrombocytopenic, IdiopathicMaleHumansAgedSulbactamAnti-Bacterial AgentsPiperacillinPiperacillin, Tazobactam Drug CombinationPenicillanic AcidMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Piperacillincefoperazonecross-reactionsulbactamtazobactamthrombocytopenia

Substanzen

CefoperazoneSulbactamAnti-Bacterial AgentsPiperacillinPiperacillin, Tazobactam Drug CombinationPenicillanic Acid

Autor:innen und Institutionen

  • Department of Pharmacy, Chongqing University Jiangjin Hospital, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China.
  • Department of Pharmacy, Central Hospital of Jiangjin District, Chongqing, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China.
  • Department of Respiratory Medicine, Chongqing University Jiangjin Hospital, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, China.
  • Department of Respiratory Medicine, Central Hospital of Jiangjin District, Chongqing, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China.

ORCID-Profile: Ling Ding

Zitieren

APA

He, X., Huang, W., Wan, X., Li, X., Chang, Q., & Ding, L. (2023). Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia. Journal of International Medical Research, 51(3). https://doi.org/10.1177/03000605231162434

Vancouver

He X, Huang W, Wan X, Li X, Chang Q, Ding L. Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia. Journal of International Medical Research. 2023;51(3). doi:10.1177/03000605231162434

BibTeX
@article{He2023,
  author = {He, Xiaoyan and Huang, Wanting and Wan, Xiong and Li, Xiaoya and Chang, Qiuhong and Ding, Ling},
  title = {Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia},
  journal = {Journal of International Medical Research},
  year = {2023},
  volume = {51},
  number = {3},
  doi = {10.1177/03000605231162434}
}
Kostenlos starten →